About AIA Company

AIA Holdings Limited and its subsidiaries (“AIA” or the “Collection”) are the largest pan-Asian independent listed drug insurance clusters, covering 18 markets, including mainland China, Hong Kong Special Administrative Region, Thailand, Singapore, Malaysia, Australia, Cambodia, Indonesia, Myanmar, New Zealand, Philippines, South Korea, Sri Lanka, Taiwan, Vietnam, Brunei and Macau S.A.R., as well as 49% of the profits of Indian joint ventures. Furthermore, AIA holds 24.99% of China Post Drug Insurance Co., Ltd. AIA's business achievements today can be traced back to 1919, the birthplace of Shanghai over a century ago. In terms of life insurance premiums, they are concentrated in the same industry in Asia (excluding Japan) and have a lower ranking than most markets. As of December 31, 2023, the total capital raised was estimated at US$286 billion. AIA provides a range of products and services, covering life insurance accidents and health insurance and savings accounts to meet the needs of individual customers in terms of long-term savings and protection. In addition, this collection also provides corporate customers with reminder benefits, credit insurance, and retirement protection services. Gathering provides services to more than 42 million individual insurance policy holders and more than 18 million health insurance participants through a network of popular agents, partners and workers all over Asia. AIA Holdings Limited is listed on the main board of the Hong Kong Joint Stock Exchange Limited. The stock code tests “1299] (HKD counter) and “81299] (RMB counter); its US Depositary Securities (Level 1) are traded on the OTC market, with the transaction code “AAGIY”.